BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Oct. 18, 2017
View Archived Issues
TG Therapeutics reports outcome from FDA meeting on GENUINE trial of ublituximab
Read More
APBA3 and MCF2 gene methylation status to predict psychotherapy response in BPD
Read More
Pembrolizumab shows activity in phase II study in thymic epithelial tumors
Read More
Bayer submits marketing authorization application for BAY-94-9027 in Japan
Read More
Preclinical and clinical results presented for poziotinib in the treatment of NSCLC
Read More
Charleston Laboratories resubmits CL-108 NDA
Read More
Biosimilar GP-2017 shows efficacy similar to adalimumab in psoriasis patients
Read More
Xenon Pharmaceuticals begins phase I study of XEN-1101
Read More
Amneal Pharmaceuticals and Impax Laboratories announce merger
Read More
Takeda and HemoShear partner to discover and develop novel therapeutics for liver diseases
Read More
Teva submits BLA in U.S. for fremanezumab
Read More
Promentis studies safety of SXC-2023 in healthy volunteers in new phase I trial
Read More
Ignyta's entrectinib obtains PRIME designation from EMA
Read More
FDA clears Incysus's IND for gamma-delta T-cell immunotherapy
Read More
Merck KGaA presents novel cyclophilin inhibitors
Read More
Mutabilis joins ENABLE project
Read More
ProMIS Neurosciences' AD candidate selectively binds to amyloid beta oligomers
Read More
Gemini Therapeutics completes series A financing
Read More
ACY-241 in combination with nivolumab shows antitumoral activity in refractory NSCLC
Read More
Mitsubishi Tanabe Pharma identifies new CYP450 11B2 inhibitors
Read More
Tonix Pharmaceuticals gives update on Tonmya CMC guidance meeting with FDA
Read More
Novel griseofulvin derivatives discovered by Daiichi Sankyo
Read More
Acticor Biotech reaches agreement on phase I study of ACT-107
Read More
Cue Biopharma describes novel 4-1BBL variant immunomodulatory polypeptides
Read More
New twist-related protein 1 vaccines patented by Asahikawa Medical University
Read More